All In Biotech

Drug Trial Radar · NCT00941798

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

A Randomized, Multi-center, Parallel Group, Double Blind, Study to Assess the Safety of QMF Twisthaler® (500/400 µg) and Mometasone Furoate Twisthaler® (400 µg) in Adolescent and Adult Patients With Persistent Asthma

Last checked: Nov 19, 2026Latest source record: Aug 31, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 2,283 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,283

Actual

Start

Jul 2009

Primary completion

May 2011

Study completion May 2011

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Jul 20, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study CQMF149A2210 evaluated the safety of QMF149 Twisthaler® 500/400 μg, a fixed dose combination of indacaterol 500 μg, a once daily β2 agonist, and mometasone furoate 400 μg, an inhaled corticosteroid (ICS) that is approved for use in the treatment of asthma. The objective of this safety trial was to assess the effect of treatment on the incidence of serious asthma exacerbations, defined as asthma related hospitalization and/or intubation and/or death. This was an event driven trial.

Conditions

  • Asthma

Interventions

  • QMF149 Twisthaler®Drug

    Once daily via multi-dose dry-powder inhaler

  • Mometasone Twisthaler®Drug

    Once daily via multi-dose dry-powder inhaler

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to First Serious Asthma ExacerbationTime frame: Up to 21 months

Locations

146 sites in 9 countries. Site status is shown where the registry gives one.

  • Novartis Investigator Site

    Birmingham, Alabama

  • Novartis Investigator Site

    Buena Park, California

  • Novartis Investigator Site

    Encinitas, California

  • Novartis Investigator Site

    Fullerton, California

  • Novartis Investigator Site

    Long Beach, California

  • Novartis Investigator Site

    Los Angeles, California

  • Novartis Investigator Site

    Orange, California

  • Novartis Investigator Site

    Riverside, California

  • Novartis Investigator Site

    San Diego, California

  • Novartis Investigator Site

    San Jose, California

  • Novartis Investigator Site

    San Mateo, California

  • Novartis Investigator Site

    Vista, California

  • Novartis Investigator Site

    Walnut Creek, California

  • Novartis Investigator Site

    Denver, Colorado

  • Novartis Investigator Site

    Engelwood, Colorado

  • Novartis Investigator Site

    Lakewood, Colorado

  • Novartis Investigator Site

    Wheat Ridge, Colorado

  • Novartis Investigator Site

    Clearwater, Florida

  • Novartis Investigator Site

    Clearwater, Florida

  • Novartis Investigative Site

    Miami, Florida

  • Novartis Investigative Site

    Miami, Florida

  • Novartis Investigator Site

    Port Charlotte, Florida

  • Novartis Investigator Site

    Sarasota, Florida

  • Novartis Investigative Site

    South Miami, Florida

  • Novartis Investigator Site

    Tampa, Florida

  • Novartis Investigative Site

    Albany, Georgia

  • Novartis Investigative Site

    Columbus, Georgia

  • Novartis Investigative Site

    Savannah, Georgia

  • Novartis Investigator Site

    Couer D'Alene, Idaho

  • Novartis Investigator Site

    Chicago, Illinois

  • Novartis Investigator Site

    Normal, Illinois

  • Novartis Investigator Site

    River Forest, Illinois

  • Novartis Investigator Site

    Skokie, Illinois

  • Novartis Investigator Site

    Springfield, Illinois

  • Novartis Investigator Site

    Evansville, Indiana

  • Novartis Investigator Site

    Indianapolis, Indiana

  • Novartis Investigator Site

    Iowa City, Iowa

  • Novartis Investigator Site

    Topeka, Kansas

  • Novartis Investigator Site

    Owensboro, Kentucky

  • Novartis Investigator Site

    Metarie, Louisiana

Showing 40 of 146 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.